There has been a lapse in appropriated federal funds as of October 1, 2025. Grants.gov and Simpler.Grants.gov will still be available, but service may be delayed with reduced Federal support staff presence.
For those programs affected by the funding lapse, the Grants.gov and Simpler.Grants.gov systems will accept and store applications until such time as the responsible awarding agency has the authority and funding to return to normal business operations.
Partnership Intermediary Agreement (PIA) Sole Source
Agency: ACC-APG-Edgewood
Assistance Listings: 12.630 -- Basic, Applied, and Advanced Research in Science and Engineering
Description
The U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC) intends to award a no-cost, in-kind cooperative agreement with the Maryland Technology Development Corporation (TEDCO), awarded non-competitively under 32 CFR § 22.305(b)(2). TEDCO’s designation as an independent instrumentality of the State of Maryland, its embedded support functions, and its dual-sector expertise uniquely position it to accelerate technology transition efforts aligned with DoD mission needs. Given TEDCO’s unmatched qualifications and regional integration, competitive solicitation is deemed impracticable.
Eligibility
Eligible applicants
Government
- State governments
Additional information
Grantor contact information
Description
Contract Specialist
Documents
No documents are currently available.
Link to additional information
--
Closing: October 2, 2025
Award
$--
Program Funding
1
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
W911SR2520002
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Other
Opportunity Category Explanation:
Intent for a Partnership Intermediary Agreement (PIA) Sole Source to TEDCO
Category of Funding Activity:
Science technology and other research and development
Category Explanation:
History
Version:
1
Posted date:
September 17, 2025
Archive date:
November 1, 2025
